- AZ Posts 23% Rise in 2009 Core Profit (PharmaTimes)
- P&G’s Product and Stock Prices Take Stage (The Wall Street Journal)
- Merck Granted European Approval for New Fertility Treatment ELONVA (TradingMarkets)
- EMA Calls for Opinions on its Road Map 2015 (PharmaTimes)
- New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas (World Pharma News)
- Drugmaker Eli Lilly Reports 4Q Profit, Sales Jump (PharmaLive)
- Gilead Receives Notification Of ANDA Filing For Viread (Pharmaceutical Business Review)
- EC Will Keep Pressure on Pharma Sector, Say Lawyers (PharmaTimes)
- Two Million Needles Recalled By FDA (RedOrbit)
- Teva Obtains Favorable Court Decision for Generic Brain Cancer Drug (TradingMarkets)
- FDA Will Take Extra 3 Months on Sepracor’s Stedesa (BusinessWeek)
- Bristol-Myers Earnings Beat Analyst Estimates on Revenue Gains (BusinessWeek)
- The US to Continue to be the Biggest Market for Medical Aesthetic Devices (Live-PR)
SUBSCRIBE